Skip Nav Destination
Acta Haematologica 2024, Vol. 147, No. 1
Issues
Acta Haematologica 2024, Vol. 147, No. 1
Chronic Lymphocytic Leukaemia (CLL) in the Era of New Targeted Therapies
Editorial
Chronic Lymphocytic Leukemia: Novel Perspectives – How to Teach an Old Dog New Tricks
Acta Haematol (2024) 147 (1): 5–7.
https://doi.org/10.1159/000533232
Review
Chronic Lymphocytic Leukemia: Disease Biology
Acta Haematol (2024) 147 (1): 8–21.
https://doi.org/10.1159/000533610
Importance of Minimal Residual Disease in the Era of Targeted Therapies in Chronic Lymphocytic Leukemia
Acta Haematol (2024) 147 (1): 22–32.
https://doi.org/10.1159/000534846
Prognostic Markers in the Era of Targeted Therapies
Acta Haematol (2024) 147 (1): 33–46.
https://doi.org/10.1159/000533704
Frontline Therapy in Chronic Lymphocytic Leukemia
Acta Haematol (2024) 147 (1): 47–59.
https://doi.org/10.1159/000534730
COVID-19 in Patients with Chronic Lymphocytic Leukemia: What Have We Learned?
Acta Haematol (2024) 147 (1): 60–72.
https://doi.org/10.1159/000534540
Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of Novel Agents
Acta Haematol (2024) 147 (1): 73–83.
https://doi.org/10.1159/000533664
Cellular Therapy in Chronic Lymphocytic Leukemia: Have We Advanced in the Last Decade?
Acta Haematol (2024) 147 (1): 99–112.
https://doi.org/10.1159/000534341